Protocol
CJC-1295 DAC (5mg Vial)
Complete dosage protocol and reconstitution guide for CJC 1295 DAC (5mg Vial).
Calculator preset
Run the vial math before tracking.
At 2.5 mg/mL, 1 unit = 25 mcg (0.01 mL); 500 mcg = 20 units and 1000 mcg = 40 units on a U-100 syringe (units = dose ÷ 2.5 mg/mL).
01 · At a glance
Quickstart Highlights
CJC-1295 DAC is a long-acting synthetic analog of growth hormone-releasing hormone (GHRH). The DAC (Drug Affinity Complex) modification binds reversibly to albumin, extending the peptide’s half-life to approximately 6–8 days [1] . By stimulating pituitary GHRH receptors, CJC-1295 DAC increases GH secretion and circulating IGF-1 in a dose-dependent manner [2] . This educational protocol presents a twice-weekly subcutaneous approach using a practical dilution for clear insulin-syringe measurements.
02 · Dosing & reconstitution
Dosing & Reconstitution Guide
A practical calculator-ready setup based on the imported protocol reference. Use these values as a math starting point, then verify every entry against your own vial, diluent, and professional guidance.
Standard / Gradual Approach (2 mL = 2500 mcg/mL)
300–1000 mcg per injection, twice weekly (gradual titration).
Reconstitution Steps
- Confirm the vial amount, unit, and diluent amount before entering values in the calculator.
- Add diluent slowly down the inner wall of the vial when reconstitution is appropriate for the compound.
- Swirl or roll gently until dissolved; avoid shaking unless the product instructions specifically say otherwise.
- Label the vial with the date and concentration, then store according to the protocol and product instructions.
03 · What you'll need
Supplies Needed
Keep this as a planning checklist. TNHL does not sell or verify supplies on this page, and no supplier quality claims are made here.
- 12 weeks ≈ 4 vials (~18.2 mg total)
- 16 weeks ≈ 6 vials (~26.2 mg total)
- 8 weeks: 16 syringes
- 12 weeks: 24 syringes
- 16 weeks: 32 syringes
- 8 weeks (3 vials): 6 mL → 1 × 10 mL bottle
- 12 weeks (4 vials): 8 mL → 1 × 10 mL bottle
- 16 weeks (6 vials): 12 mL → 2 × 10 mL bottles
- Per week: 4 swabs (2
- per injection × 2 injections)
- 8 weeks: 32 swabs → recommend 1 × 100-count box
- 12 weeks: 48 swabs → recommend 1 × 100-count box
Protocol Overview
- Goal: Support sustained GH and IGF-1 elevation for research into GH-axis effects [1] .
- Schedule: Twice-weekly subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).
- Dose Range: 300–1000 mcg per injection with gradual titration.
- Reconstitution: 2.0 mL per 5 mg vial (2.5 mg/mL) for accurate unit measurements.
- Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.
Dosing Protocol
- Suggested twice-weekly titration approach.
- Start: 300 mcg per injection twice weekly; increase by ~250 mcg every 2 weeks as tolerated.
- Target: 750–1000 mcg per injection by Weeks 5–12.
- Frequency: Twice per week (subcutaneous), spaced 3–4 days apart.
- Cycle Length: 8–12 weeks; optional extension to 16 weeks.
- Timing: Consistent timing (e.g., evenings); rotate injection sites.
Storage Instructions
- Lyophilized: freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) ; avoid freeze–thaw cycles.
- Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.
- Keep mixed and unmixed items clearly labeled so inventory and dose logs stay accurate.
04 · Good to know
Important Notes
- Practical considerations for consistency and safety.
- Use new sterile insulin syringes; dispose in a sharps container.
- Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
- Inject slowly; wait a few seconds before withdrawing the needle.
- Document each dose, injection site, and timing to maintain consistency.
- The DAC modification provides sustained release; maintain consistent twice-weekly scheduling.
- The 5 mg vial provides more doses per vial, reducing reconstitution frequency.
05 · How it works
How This Works
CJC-1295 DAC is a long-acting synthetic analog of growth hormone-releasing hormone (GHRH).
The DAC (Drug Affinity Complex) modification binds reversibly to albumin, extending the peptide’s half-life to approximately 6–8 days [1] .
By stimulating pituitary GHRH receptors, CJC-1295 DAC increases GH secretion and circulating IGF-1 in a dose-dependent manner [2] .
The library page pairs that educational context with calculator-ready vial math, so users can understand the protocol structure and then track their own entered values in one place.
06 · Daily habits
Lifestyle Factors
- Keep meals, training, sleep, and recovery notes in the journal so trends are easier to review.
- Track body metrics only if they are relevant to the user's goal and approved data sources.
- Use consistent timing and logging habits so adherence data is meaningful.
07 · What to expect
Potential Benefits & Side Effects
- CJC-1295 DAC observations should be recorded conservatively: expected research endpoints, tolerability notes, injection-site reactions when applicable, sleep, appetite, energy, mood, and any adverse or unusual response.
- This section is not a claim of therapeutic benefit.
08 · Technique
Injection Technique
- Wash hands with soap and water.
- Wipe the vial stopper and chosen site with alcohol, then let both dry.
- Confirm the vial concentration, calculator result, and intended draw amount before loading the syringe.
- Use the route and needle technique directed by a qualified professional or product instructions.
- For subcutaneous injections, rotate sites and inject slowly to limit leakage and irritation.
- Do not reuse needles or syringes.
- Dispose of sharps in a puncture-resistant container.
- Return stored items promptly to the correct temperature.
- Log dose, site, date, time, inventory change, and any observation.
09 · Evidence
References
Related pages